VOTIS SIGNED

Project "VOTIS" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

 Project objective

Epidemiological studies confirm a link between diabetes and increased PAD (Peripheral Arterial Diseases) prevalence, and diabetes is associated with a two- to four-fold increase in PAD compared to non-diabetics. PAD impedes resolution of small surface wounds and is an important predictor of diabetic foot ulcers (DFUs). DFUs are a chronic complication of diabetes. Recent studies suggest that diabetics have a 25% risk of developing a DFU over their lifetime, and when a person with PAD develops a DFU, often the DFU will not heal. Therefore, the physician who examines a patient with diabetes and foot ulcer should always assess the vascular status of lower limbs. Nevertheless, PAD detection and the assessment of its severity is a clinical challenge in diabetic patients with foot disease, due to altered clinical presentation of PAD and limitations of the diagnostic procedures: many methods analyse only the outer surface of the sk VOTIS utilises an innovative, non-invasive and patented methodology to assess the physiological health of the lower limb even before tangible symptoms appear. “Time is tissue.”VOTIS aims to promote necessary changes in the armamentarium for treating peripheral artery disease (PAD), ischaemia and low perfusion rates in diabetics. These changes support detection and preventative healthcare and will improve control over disease progression. This, in turn, will lengthen the path to necessary amputations and reduce associated health consequences and their costs. Our business opportunity is very attractive, considering the growing number of diabetics at risk for foot amputations as well as the limited ability of currently-available solutions to detect, locate, and quantify the severity of peripheral artery disease (PAD). We plan to increase our understanding of international market conditions and related risks. The current feasibility study will help us to deepen both our roll-out plan and our plan to scaleup VOTIS